Indacaterol vs placebo
Improvement in symptoms: number of participants with clinically significant improvement: using TDI focal score (≥ 1 unit) · patients with chronic obstructive pulmonary disease
Indacaterol leads to higher number of participants with clinically significant improvement in… compared with placebo (high certainty).
1 finding from 1 review
- Indacaterol, a once‐daily beta₂‐agonist, versus twice‐daily beta₂‐agonists or placebo for chronic obstructive… 2015 · Cochrane Headline outcomes onlyOR 1.96 [1.73, 2.22]8 studies · 4577 participantsHigh